Abstract
Changes induced by i.v. and subcutaneous teprotide in plasma renin, angiotensin I, angiotensin II, aldosterone and bradykinin were studied in a renal transplant patient with severe high renin hypertension, before and after trinephrectomy. The immediate reduction in BP produced by teprotide was not solely attributable to the inhibition of conversion of angiotensin I to angiotensin II, because there was also a transient increase in serum bradykinin; however, the prolonged antihypertensive effect of teprotide appeared independent of bradykinin. After trinephrectomy, teprotide lowered systolic BP but had no significant effect on diastolic BP or plasma bradykinin. beta-Blockade prevented the secondary increase in plasma renin which followed teprotide, thereby potentiating its anti-hypertensive effect.
References
Sep 8, 1979·Lancet·C I JohnstonP G Matthews
Jul 1, 1975·Circulation Research·A NasjlettiJ C McGiff
Mar 1, 1976·Circulation·J SanchoE Haber
Jan 1, 1976·Annual Review of Biochemistry·R L Soffer
Jul 28, 1977·The New England Journal of Medicine·G H Williams, N K Hollenberg
Jul 1, 1979·Hypertension·J M VinciH R Keiser
Mar 1, 1979·Hypertension·S L SwartzR G Dluhy
Feb 1, 1975·Circulation Research·E G Erdös
Dec 15, 1977·Experientia·N PapanicolaouP Milliez
May 1, 1978·Circulation Research·H Thurston, J D Swales
Sep 23, 1978·British Medical Journal·M J VandenburgE J Rucinska
Jan 1, 1977·Circulation Research·M R Rosen, B F Hoffman
Sep 1, 1973·Clinical Science and Molecular Medicine·R FraserJ Young
Feb 2, 1980·British Medical Journal·A J Man in 't VeldM A Schalekamp
Apr 19, 1980·British Medical Journal·B R LeslieE D Vaughan